Earnings · China A-shares

Hualan Biological Vaccine Inc. Class A (301207) earnings

Hualan Biological Vaccine Inc. Class A published its Q3 report on 2026-10-27: net profit -103.36% year on year, -143.01% excluding one-off items. Wave Radar's earnings-quality score is 59 of 100 (Questionable). The stock moved -20.51% in the 3 trading days after the report.

Report
Q3 report
Published
2026-10-27
Period end
2026-09-30
Net profit YoY
-103.36%
Excl. one-offs YoY
-143.01%
Result
Bad / loss
Quality score
59
Quality
Questionable
Open earnings in Wave Radar

Stock move after the report

Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.

AfterReturnvs index
1 day-13.79%—
3 days-20.51%—
7 days-11.74%—
14 days-18.52%—

Report history

Over the last 8 reports, net profit grew year on year in 2 of them. The stock rose in the 3 trading days after 5 of 8 reports (average -0.54%).

ReportPublishedNet profitProfit YoYExcl. one-offs YoYRevenue YoYEPSROE3 days after30 days after30d vs index
2026 Q3 report2026-10-28-¥4.45M-103.36%—-62.67%-0.01-0.08%-20.51%——
2026 interim report2026-08-29¥36.44M+75.23%+213.99%-25.98%0.060.65%-3.26%+5.95%+15.28%
2026 Q1 report2026-04-27¥37.37M+14.00%+69.61%+10.27%0.060.65%+2.45%-8.14%-7.84%
2025 annual report2026-03-28¥182.92M-10.99%+9.38%+6.62%0.313.08%+4.75%+5.58%-3.78%
2025 Q3 report2025-10-30¥132.31M-50.51%-56.02%-15.81%0.222.20%+11.23%+10.70%+15.45%
2025 interim report2025-08-28¥20.80M-17.71%+40.04%+68.77%0.040.35%+0.77%-2.58%-8.08%
2025 Q1 report2025-04-28¥32.78M-15.06%+8.89%-29.05%0.060.54%+0.57%+7.70%+4.45%
2024 annual report2025-03-29¥205.52M-76.10%-84.12%-53.21%0.343.37%-0.29%-6.04%-4.48%

The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.

Stock valuations: 301207

How to read this

Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.

Figures are generated automatically from Wave Radar's published market data and refresh after each market close.